TARGETING THE TUMOR MICROENVIRONMENT FOR CANCER PREVENTION AND THERAPY
Friday, September 15: 4:30PM - 5:15PM ( .75 CME credit hours)
 
ABOUT THE LECTURE: 
  • Provide a basic understanding of the biochemical characteristics of cancer.
  • Understand that conventional cancer treatments have limited potential.
  • Recognize that cancer is primarily a metabolic disease.
  • Recognize that cancer can be treated and prevented with non-toxic metabolic therapies that target and kill tumor cells while enhancing the energy efficiency of mitochondria in normal cells.
  • Present a case that utilized the RECNAC 2 protocol  as treatment for advanced cancer.
 

Michael J. González, PhD
ABOUT DR. GONZALEZ:
Dr. Michael J. Gonzalez BS, MS, MHSN, CNS, DSc, NMD, PhD, FANMA, FACN is Professor at the Nutrition Program, School of Public Health in the Medical Sciences Campus, University of Puerto Rico and Adjunct faculty at the University of Western States And EDP University. Dr. Gonzalez is a Fellow of the American College of Nutrition, and has authored over 200 scientific publications. He serves as a member on multiple scientific Editorial Boards. He has served as consultant for several companies where he has been responsible for designing formulations of nutritional supplements and pharmaceutical products. He has also been a consultant for The Center for the Improvement of Human Functioning (now Riordan Clinic), in Wichita, Kansas. He has obtained several research awards for his work on Nutrition and Cancer. He is currently Co- Director of RECNAC II project, and Research Director of the InBioMed Project Initiative. Dr. Gonzalez also serves as a nutrition consultant to the Puerto Rican Basketball National Team and is part of the Medical Commission of the Puerto Rican Basketball Federation. He was part of the Medical Staff of the Vaqueros de Bayamon professional basketball team in Purto Rico. He is in a part time clinical practice with Dr. Miguel J Berdiel in Ponce, PR. In December 2013,Dr. Gonzalez was exalted as Distinguished Ponceño in Medicine. In 2015 he was selected as member to the prestigious Puerto Rican Academy of Arts and Sciences and to the Iberoamerican Academy of Culture and Sciences.

Doctor González is one of the founders of InBioMed, leaders in the development of non-toxic chemotherapy treatments for cancer. The findings of their work with Intravenous Vitamin C as an anti-cancer agent, published in 2002, were confirmed by the NIH in 2005. They published the first Phase-I clinical study utilizing Intravenous Vitamin C for treatment of terminal cancer patients in 2005, and also published in 2005 the most comprehensive review on Vitamin C and Cancer, as a follow-up on the work of two times Nobel Laureate, Dr. Linus C. Pauling. They have brought many new concepts into the scientific field, such as the Bioenergetic theory of carcinogenesis, the systemic saturation phenomenon of intravenous vitamin C, the metabolic correction concept for disease treatment and prevention. Dr. Gonzalez was inducted to the International Hall of fame of Orthomolecular Medicine April, 2016. He is one of the first hispanoamerican and Puerto Rican to be inducted to the International Hall of fame of Orthomolecular Medicine.

Books: Doctors Gonzalez, Miranda-Massari and Saul’s book “I Have Cancer What Should I do: The Orthomolecular Guide to Cancer Management” provides evidence based recommendations for an integrative approach for those dealing with cancer and seeking to improve quality of life and survival. In 2014 they published the book” New Insights Vitamin C and Cancer” for Springer-Larger. Dr. Gonzalez is actually finishing a book on Metabolic Correction and Diabetes and writing a chapter on metabolic correction and disease for a Functional medicine textbook.

DISCLOSURE STATEMENT
Dr. González has indicated that he has no financial relationships with any commercial supporters.




ACAM MEMBER SERVICES: Rachelle Morehead
1.800.532.3688  |  Rachelle.Morehead@acam.org

ACAM EXHIBITOR SERVICES: Jessica Ulmen
1.800.532.3688  |  Jessica.Ulmen@acam.org